Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Stelara® (ustekinumab) – New indication
October 21, 2019 - Janssen announced the FDA approval of Stelara (ustekinumab), for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).
